Molecular Pathology Laboratory Network

Clinical Care Options® (CCO) is offering an online presentation about individualized therapies for metastatic colorectal cancer. The certified interactive course, led by Alan P. Venook, MD, offers CME credits to participating physicians and explores the future of personalized patient, with a focus on predictive biomarkers.

Upon completion of this activity, participants should be able to:

• Discuss current evidence regarding treatment of metastatic colorectal cancer with targeted therapeutic agents
• Identify biomarkers with predictive ability in the setting of colorectal cancer
• Apply lessons learned from recent clinical trials in the clinical management of patients with colorectal cancer
• Compare the efficacy of various combination regimens for the treatment of metastatic colorectal cancer based on patient characteristics and other factors

For more information about the virtual presentation, visit the CCO website.